Try our Advanced Search for more refined results
W.L. Gore & Associates Inc. et al v. C.R. Bard Inc.
Case Number:
1:11-cv-00515
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 20, 2017
Gore Can't Slip Invalidity Verdict In Stent Patent Row
A Delaware federal judge on Wednesday denied W.L. Gore & Associates Inc.'s bid to toss a jury's finding that Gore's patent relating to a stent device, which Gore had unsuccessfully alleged was infringed by C.R. Bard Inc., is invalid over prior art.
-
March 08, 2017
Bard Stent Grafts Don't Infringe Gore Patents, Jury Finds
A Delaware federal jury of four men and four women determined Wednesday that an ultrathin stent graft device produced by C.R. Bard Inc. does not infringe a patent held by W.L. Gore & Associates Inc. and that the patent is invalid over prior art.
-
March 01, 2017
Long-Awaited IP Trial Between WL Gore, CR Bard Kicks Off
A long-delayed intellectual property trial over stent graft patents between bitter rivals C.R. Bard Inc. and W.L. Gore & Associates Inc. kicked off in Delaware on Wednesday with Gore suggesting Bard copied its invention and Bard arguing that precise technical information shows that not to be so.
-
February 08, 2017
Gore Must Pay Fees After Sanctions Bid Fails In IP Row
A Delaware federal judge on Wednesday ordered W.L. Gore & Associates to pay a portion of the attorneys' fees that C.R. Bard incurred while responding to the Gore-tex maker's "aggressive" pursuit of sanctions against it and its attorneys in litigation over a stent patent which Gore claims Bard has infringed.
-
August 11, 2016
Bard Again Slams Gore's 'Baseless' Sanctions Bid In IP Suit
C.R. Bard again slammed W.L. Gore & Associates' "baseless" sanctions bid in a stent patent case, telling a Delaware federal judge in a letter Wednesday that there is no way the motion was brought in good faith and that it could have ruined attorneys' careers.
-
August 08, 2016
CR Bard Blasts Rival's 'Baseless' Sanctions Bid In IP Suit
C.R. Bard asked a Delaware federal judge Friday for attorneys' fees it incurred over W.L. Gore & Associates' sanctions bid in a stent patent case, saying the "potentially career-ending allegations" that it was sitting on damaging information to delay a trial were "baseless."
-
July 29, 2016
WL Gore Can't Recover Lost Profits In Stent IP Row: Judge
A Delaware federal judge has ruled that W.L. Gore & Associates Inc. is not entitled to recover lost-profit damages estimated to exceed $100 million in its long-running patent fight over a heart stent against C.R. Bard Inc., according to a ruling unsealed Friday.
-
July 11, 2016
Bard Says Jury Shouldn't Decide Triple Damages Bid In IP Suit
C.R. Bard Inc. has urged a Delaware federal court in a case worth $100 million or more not to allow a jury to decide whether its alleged infringement of a W.L. Gore & Associates Inc. stent patent was willful and therefore worthy of enhanced damages, while Gore argued otherwise.
-
March 17, 2016
Gore-Tex Maker Says Antics In Stent IP Row Need Sanctions
A Delaware federal case over a stent patent with $100 million or more at stake took a side trip into a sanctions hearing Thursday, with W.L. Gore & Associates Inc. accusing medical device maker C.R. Bard Inc. of delaying trial with eleventh-hour claims of damaging information.
-
December 07, 2015
Judge Postpones Stent IP Trial Between WL Gore and CR Bard
A Delaware federal judge reluctantly agreed Monday to postpone the trial between C.R. Bard Inc. and rival medical device maker W.L. Gore & Associates Inc. over stent graft patents at the joint request of the two sides minutes before the jury pool was to be brought into court.